Related Experiment Video
Updated: Feb 24, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic
Yuxue Chen1, Hao Tian1, Ensheng Yao1
1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China.
Abstract:
Chronic cerebral hypoperfusion induced cerebrovascular white matter lesions (WMLs) are closely associated with cognitive impairment and other neurological deficits. The mechanism of demyelination in response to hypoperfusion has not yet been fully clarified. Soluble epoxide hydrolase (sEH) is an endogenous key enzyme in the metabolic conversion and degradation of P450 eicosanoids called epoxyeicosatrienoic acids. Inhibition of sEH has been suggested to represent a prototype "combination therapy" targeting multiple mechanisms of stroke injury with a single agent. However, its role in the pathological process after WMLs has not been clarified. The present study was to investigate the role of a potent sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), on multiple elements in white matter of mice brain after chronic hypoperfusion. Adult male C57BL/6 mice were subjected to bilateral carotid artery stenosis (BCAS) to induce WMLs. Administration of TPPU significantly inhibited microglia activation and inflammatory response, increased M2 polarization of microglial cells, enhanced oligodendrogenesis and differentiation of oligodendrocytes, promoted white matter integrity and remyelination following chronic hypoperfusion. Moreover, these cellular changes were translated into a remarkable functional restoration. The results suggest that sEH inhibition could exert multi-target protective effects and alleviate cognitive impairment after chronic hypoperfusion induced WMLs in mice.
Insights
Inhibition of soluble epoxide hydrolase (sEH) with TPPU protected white matter integrity and improved cognitive function in mice with chronic cerebral hypoperfusion. This suggests sEH inhibition is a promising therapeutic strategy for white matter lesions.
Area of Science:
- Neuroscience
- Pharmacology
- Pathology
Background:
- Chronic cerebral hypoperfusion causes white matter lesions (WMLs) linked to cognitive decline.
- The precise mechanisms of demyelination in WMLs remain unclear.
- Soluble epoxide hydrolase (sEH) metabolizes epoxyeicosatrienoic acids and is a potential therapeutic target.
Purpose of the Study:
- To investigate the therapeutic potential of a potent sEH inhibitor, TPPU, in a mouse model of chronic hypoperfusion-induced WMLs.
- To elucidate the effects of sEH inhibition on white matter pathology and cognitive function.
Main Methods:
- Adult male C57BL/6 mice underwent bilateral carotid artery stenosis (BCAS) to induce chronic hypoperfusion and WMLs.
- Mice were treated with the sEH inhibitor TPPU.
- Evaluated microglia activation, inflammatory response, oligodendrogenesis, white matter integrity, remyelination, and cognitive function.
Main Results:
- TPPU administration significantly reduced microglia activation and inflammation.
- TPPU treatment promoted M2 microglial polarization, enhanced oligodendrogenesis, and improved oligodendrocyte differentiation.
- White matter integrity and remyelination were promoted, leading to functional recovery and cognitive improvement.
Conclusions:
- sEH inhibition by TPPU demonstrates multi-target protective effects against chronic hypoperfusion-induced WMLs.
- Targeting sEH offers a promising therapeutic avenue for alleviating cognitive impairment associated with WMLs.
More Related Videos
08:41Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
Published on: December 29, 2016
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023